Statistics for Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.
Total visits
| views | |
|---|---|
| Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer. | 100 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 2 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| Eur J Cancer. 2016.pdf(legacy) | 2 |
Top country views
| views | |
|---|---|
| United States | 57 |
| China | 13 |
| Brazil | 7 |
| Canada | 4 |
| Portugal | 3 |
| France | 2 |
| United Kingdom | 2 |
| Australia | 1 |
| Belgium | 1 |
| Ireland | 1 |
| Italy | 1 |
| South Korea | 1 |
| Latvia | 1 |
| Moldova | 1 |
| Macedonia | 1 |
| Netherlands | 1 |
| Seychelles | 1 |
| Ukraine | 1 |